{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:48:49Z","timestamp":1792900129903,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/nm.2131","type":"journal-article","created":{"date-parts":[[2010,4,4]],"date-time":"2010-04-04T13:46:32Z","timestamp":1270388792000},"page":"420-428","source":"Crossref","is-referenced-by-count":336,"title":["Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia"],"prefix":"10.1038","volume":"16","author":[{"given":"Franck","family":"Lebrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samly","family":"Srun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stieneke","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Br\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mathivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Larriv\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-L\u00e9on","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J J","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes J","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Repke J","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L","family":"Mummery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,4]]},"reference":[{"key":"BFnm2131_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister, K.A. et al. Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345\u2013351 (1994).","journal-title":"Nat. Genet."},{"key":"BFnm2131_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson, D.W. et al. Mutations in the activin receptor\u2013like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13, 189\u2013195 (1996).","journal-title":"Nat. Genet."},{"key":"BFnm2131_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.cardiores.2004.10.036","volume":"65","author":"F Lebrin","year":"2005","unstructured":"Lebrin, F., Deckers, M., Bertolino, P. & Ten Dijke, P. TGF-\u03b2 receptor function in the endothelium. Cardiovasc. Res. 65, 599\u2013608 (2005).","journal-title":"Cardiovasc. Res."},{"key":"BFnm2131_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tcm.2007.11.003","volume":"18","author":"F Lebrin","year":"2008","unstructured":"Lebrin, F. & Mummery, C.L. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc. Med. 18, 25\u201332 (2008).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnm2131_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani, F.S. & Shovlin, C.L. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur. J. Hum. Genet. 17, 860\u2013871 (2009).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnm2131_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000072411","volume":"110","author":"A Cirulli","year":"2003","unstructured":"Cirulli, A. et al. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol. 110, 29\u201332 (2003).","journal-title":"Acta Haematol."},{"key":"BFnm2131_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cardiores.2005.04.028","volume":"68","author":"M Letarte","year":"2005","unstructured":"Letarte, M. et al. Reduced endothelial secretion and plasma levels of transforming growth factor-\u03b21 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc. Res. 68, 155\u2013164 (2005).","journal-title":"Cardiovasc. Res."},{"key":"BFnm2131_CR8","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1242\/dev.01529","volume":"131","author":"RL Carvalho","year":"2004","unstructured":"Carvalho, R.L. et al. Defective paracrine signalling by TGF\u03b2 in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131, 6237\u20136247 (2004).","journal-title":"Development"},{"key":"BFnm2131_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke, P. & Arthur, H.M. Extracellular control of TGF\u03b2 signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 8, 857\u2013869 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm2131_CR10","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.3748\/wjg.v13.45.5979","volume":"13","author":"J Bauditz","year":"2007","unstructured":"Bauditz, J. & Lochs, H. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J. Gastroenterol. 13, 5979\u20135984 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnm2131_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","volume":"21","author":"F Kabbinavar","year":"2003","unstructured":"Kabbinavar, F. et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)\/leucovorin (LV) with FU\/LV alone in patients with metastatic colorectal cancer. J. Clin. Oncol. 21, 60\u201365 (2003).","journal-title":"J. Clin. Oncol."},{"key":"BFnm2131_CR12","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMc0901421","volume":"360","author":"P Bose","year":"2009","unstructured":"Bose, P., Holter, J.L. & Selby, G.B. Bevacizumab in hereditary hemorrhagic telangiectasia. N. Engl. J. Med. 360, 2143\u20132144 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2131_CR13","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato, R.J., Loughnan, M.S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 91, 4082\u20134085 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2131_CR14","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0901505106","volume":"106","author":"C Therapontos","year":"2009","unstructured":"Therapontos, C., Erskine, L., Gardner, E.R., Figg, W.D. & Vargesson, N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc. Natl. Acad. Sci. USA 106, 8573\u20138578 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2131_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/gut.2003.029710","volume":"53","author":"J Bauditz","year":"2004","unstructured":"Bauditz, J., Schachschal, G., Wedel, S. & Lochs, H. Thalidomide for treatment of severe intestinal bleeding. Gut 53, 609\u2013612 (2004).","journal-title":"Gut"},{"key":"BFnm2131_CR16","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1007\/s10620-007-0067-z","volume":"53","author":"V Dabak","year":"2008","unstructured":"Dabak, V., Kuriakose, P., Kamboj, G. & Shurafa, M. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dig. Dis. Sci. 53, 1632\u20131635 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"BFnm2131_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/MEG.0b013e32832c9346","volume":"21","author":"P Kamalaporn","year":"2009","unstructured":"Kamalaporn, P. et al. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series. Eur. J. Gastroenterol. Hepatol. 21, 1347\u20131350 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnm2131_CR18","first-page":"21","volume":"16","author":"R Kurstin","year":"2002","unstructured":"Kurstin, R. Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease. Oncology (Williston Park) 16, 21\u201324 (2002).","journal-title":"Oncology"},{"key":"BFnm2131_CR19","first-page":"ELT34","volume":"87","author":"M P\u00e9rez-Encinas","year":"2002","unstructured":"P\u00e9rez-Encinas, M., Rabunal Martinez, M.J. & Bello Lopez, J.L. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia? Haematologica 87, ELT34 (2002).","journal-title":"Haematologica"},{"key":"BFnm2131_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","volume":"39","author":"M Melchert","year":"2007","unstructured":"Melchert, M. & List, A. The thalidomide saga. Int. J. Biochem. Cell Biol. 39, 1489\u20131499 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnm2131_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1083\/jcb.200701146","volume":"177","author":"L Jakobsson","year":"2007","unstructured":"Jakobsson, L., Kreuger, J. & Claesson-Welsh, L. Building blood vessels-stem cell models in vascular biology. J. Cell Biol. 177, 751\u2013755 (2007).","journal-title":"J. Cell Biol."},{"key":"BFnm2131_CR22","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/01.CIR.0000058170.92267.00","volume":"107","author":"E Torsney","year":"2003","unstructured":"Torsney, E. et al. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107, 1653\u20131657 (2003).","journal-title":"Circulation"},{"key":"BFnm2131_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau, A., Dumont, D.J. & Letarte, M. A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343\u20131351 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm2131_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10456-007-9065-1","volume":"10","author":"M Fruttiger","year":"2007","unstructured":"Fruttiger, M. Development of the retinal vasculature. Angiogenesis 10, 77\u201388 (2007).","journal-title":"Angiogenesis"},{"key":"BFnm2131_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1242\/dev.004895","volume":"135","author":"X Zhu","year":"2008","unstructured":"Zhu, X., Bergles, D.E. & Nishiyama, A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135, 145\u2013157 (2008).","journal-title":"Development"},{"key":"BFnm2131_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl, P., Johansson, B.R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B\u2013deficient mice. Science 277, 242\u2013245 (1997).","journal-title":"Science"},{"key":"BFnm2131_CR27","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","volume":"126","author":"M Hellstr\u00f6m","year":"1999","unstructured":"Hellstr\u00f6m, M., Kalen, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of PDGF-B and PDGFR-\u03b2 in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047\u20133055 (1999).","journal-title":"Development"},{"key":"BFnm2131_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1083\/jcb.153.3.543","volume":"153","author":"M Hellstr\u00f6m","year":"2001","unstructured":"Hellstr\u00f6m, M. et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543\u2013553 (2001).","journal-title":"J. Cell Biol."},{"key":"BFnm2131_CR29","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/emboj\/cdf418","volume":"21","author":"M Enge","year":"2002","unstructured":"Enge, M. et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307\u20134316 (2002).","journal-title":"EMBO J."},{"key":"BFnm2131_CR30","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1101\/gad.266803","volume":"17","author":"P Lindblom","year":"2003","unstructured":"Lindblom, P. et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835\u20131840 (2003).","journal-title":"Genes Dev."},{"key":"BFnm2131_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2003.08.129","volume":"310","author":"A Dudley","year":"2003","unstructured":"Dudley, A. et al. STI-571 inhibits in vitro angiogenesis. Biochem. Biophys. Res. Commun. 310, 135\u2013142 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm2131_CR32","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/ijc.22999","volume":"121","author":"Y Hasumi","year":"2007","unstructured":"Hasumi, Y. et al. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Int. J. Cancer 121, 2606\u20132614 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnm2131_CR33","doi-asserted-by":"publisher","first-page":"H1591","DOI":"10.1152\/ajpheart.2000.279.4.H1591","volume":"279","author":"B Vollmar","year":"2000","unstructured":"Vollmar, B., Morgenthaler, M., Amon, M. & Menger, M.D. Skin microvascular adaptations during maturation and aging of hairless mice. Am. J. Physiol. Heart Circ. Physiol. 279, H1591\u2013H1599 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnm2131_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel, K., Genove, G., Armulik, A. & Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 630\u2013638 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm2131_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1083\/jcb.105.3.1455","volume":"105","author":"A Orlidge","year":"1987","unstructured":"Orlidge, A. & D\u2032Amore, P.A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455\u20131462 (1987).","journal-title":"J. Cell Biol."},{"key":"BFnm2131_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1083\/jcb.109.1.309","volume":"109","author":"Y Sato","year":"1989","unstructured":"Sato, Y. & Rifkin, D.B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-\u03b2 1\u2013like molecule by plasmin during co-culture. J. Cell Biol. 109, 309\u2013315 (1989).","journal-title":"J. Cell Biol."},{"key":"BFnm2131_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature06868","volume":"453","author":"J Hamzah","year":"2008","unstructured":"Hamzah, J. et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453, 410\u2013414 (2008).","journal-title":"Nature"},{"key":"BFnm2131_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/dvdy.20136","volume":"231","author":"F Bajanca","year":"2004","unstructured":"Bajanca, F., Luz, M., Duxson, M.J. & Thorsteinsdottir, S. Integrins in the mouse myotome: developmental changes and differences between the epaxial and hypaxial lineage. Dev. Dyn. 231, 402\u2013415 (2004).","journal-title":"Dev. Dyn."},{"key":"BFnm2131_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/dbio.1999.9534","volume":"217","author":"HM Arthur","year":"2000","unstructured":"Arthur, H.M. et al. Endoglin, an ancillary TGF\u03b2 receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42\u201353 (2000).","journal-title":"Dev. Biol."},{"key":"BFnm2131_CR40","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/blood-2004-04-1485","volume":"104","author":"M Uutela","year":"2004","unstructured":"Uutela, M. et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104, 3198\u20133204 (2004).","journal-title":"Blood"},{"key":"BFnm2131_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163\u20131177 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnm2131_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","volume":"445","author":"M Hellstr\u00f6m","year":"2007","unstructured":"Hellstr\u00f6m, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776\u2013780 (2007).","journal-title":"Nature"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:25:26Z","timestamp":1684434326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFnm2131"],"URL":"https:\/\/doi.org\/10.1038\/nm.2131","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3800956.3533055","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}